Question:A non-inferiority test is carried out to compare a new drug
that comes with a claim...
Question
A non-inferiority test is carried out to compare a new drug
that comes with a claim...
A non-inferiority test is carried out to compare a new drug
that comes with a claim of fewer side effects to the existing
standard of care drug for shoulder injuries. Two comparisons of
efficacy are done:
The first efficacy comparison is on how quickly complete motor
function is restored (Fewer number of days=better). Given a
pre-specified margin of acceptance of 2 days, which of the
following confidence intervals (point estimate: mean number of days
for new drug - mean number of days for standard drug) would lead
you to consider the new drug non-inferior to the standard? Briefly
explain.
(-5,-3)
(-5,0)
(0,3)
(-3,4)
The second efficacy comparison is on a motor activity
assessment scale from 0 to 100 (higher=better). Given a
pre-specified margin of acceptance of 10 units, which of the
following confidence intervals (point estimate: mean activity
assessment for new drug - mean activity assessment for standard
drug) would lead you to consider the new drug non-inferior to the
standard? Briefly explain.